Sera Prognostics People in the News at Standard BioTools, Epigenomics, Centogene, Molecular Loop, Quantum-Si, More Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of May 15, 2023. Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue. People in the News: New Appointments at Thermo Fisher, Sera Prognostics, PreludeDx, More Industry Pros Suggest Proteomic Dx Technology Ready for Routine Application Premium They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge. Fresh Off LabCorp Launch, Sera Publishes Analytical Validation for PreTRM Test Premium The study details the validation of the mass spec-based preterm birth test, which the company launched nationwide last month through its agreement with LabCorp. Jan 12, 2017 Sera Prognostics' Deal with LabCorp Brings Potential Risks, Rewards Premium Jan 10, 2017 LabCorp to Distribute Sera's PreTRM Test, Lead $40M Series C Round Dec 23, 2016 Model Suggests Sera's PreTRM Test Could Offer Big Cost Savings, Though More Data Needed Premium Mar 11, 2016 With Validation Data Published, Reimbursement the Next Hurdle for Sera's PreTRM Test Premium Mar 10, 2016 Sera Publishes Validation Study of PreTRM Proteomic Test for Risk of Preterm Delivery Feb 4, 2016 Sera Prognostics Presents Results From Validation Study of PreTRM Test Premium Oct 23, 2015 Another Mass Spec Test Moves to Clinic as Sera Launches Preterm Birth Risk Panel Premium Feb 4, 2015 Sera Increases Series B Round to $25M with $5M from Gates Foundation Jan 9, 2015 Sera Planning 2015 Launch of PreTRM Proteomic Test to Assess Preterm Delivery Risk Premium Jan 7, 2015 Sera Prognostics Closes $20M Series B Financing Round Sep 6, 2013 People in the News: Lee Hood to Serve as Scientific Advisor to Sera Prognostics Premium Aug 23, 2013 Sera Completes Enrollment of 5,500 Patients for PreTRM Validation, Pushes Back Test Launch to 2014 Premium Mar 29, 2013 Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay Premium Mar 1, 2013 Sera Prognostics' 4,000-Patient Validation Study Another Sign of High-Throughput Mass Spec's Arrival Premium Feb 12, 2013 Agilent, Sera Prognostics Team on Proteomic Assays Feb 1, 2013 Stanford Spinout Carmenta Bioscience Prepping Validation Study of Preeclampsia Protein Dx Premium Jan 4, 2013 2012 Sees Rise of Targeted Proteomics and DIA-MS, Continued Clinical Push by Big Industry Players Premium Nov 7, 2012 People: Greg Critchfield Premium Oct 5, 2012 People in the News: Sera Prognostics, Biomarker Strategies Premium Sep 21, 2012 Targeted Mass Spec Slowly but Steadily Moving Toward Broader Commercial, Clinical Adoption Premium Load More Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.